The Visuo-Motor Attention Test in Boys with Attention Deficit Hyperactivity Disorder (ADHD): Methylphenidate-Placebo Randomized Controlled Trial.

To assess the visuomotor attention ability in children with ADHD and controls and their response to placebo and Methylphenidate (MPH) treatment. 36 boys with ADHD and 36 age matched typical controls were administered the visuomotor attention test (VMAT) as a baseline and following a week of MPH(IR) or placebo administered to the study group, in a randomized crossover design. A significant difference between the study and control groups was found on several VMAT measures.

The choice of freely preferred cadence by trained nonprofessional cyclists may not be characterized by mechanical efficiency.

Background: Most cycling studies involve professional cyclists. Because training may affect riding style, it is of interest to determine the physiological basis for the personal choice of cycling cadence in nonprofessional cyclists.

Methods: Eleven nonprofessional (5.

Auditory and Visual Executive Functions in Children and Response to Methylphenidate: A Randomized Controlled Trial.

The aim of the study was to assess auditory and visually based executive functions (EFs) and the effect of methylphenidate (MPH) in children with ADHD. Thirty-six boys between the ages of 8.3 and 9.

Subthalamic nucleus deep brain stimulation does not improve visuo-motor impairment in Parkinson's disease.

Objective: To evaluate how bilateral subthalamic nucleus deep brain stimulation (STN-DBS) affects visuo-motor coordination (VMC) in patients with Parkinson's disease (PD).

Background: VMC involves multi-sensory integration, motor planning, executive function and attention. VMC deficits are well-described in PD.

Visuo-motor coordination deficits and motor impairments in Parkinson's disease.

Background: Visuo-motor coordination (VMC) requires normal cognitive executive functionality, an ability to transform visual inputs into movement plans and motor-execution skills, all of which are known to be impaired in Parkinson's disease (PD). Not surprisingly, a VMC deficit in PD is well documented. Still, it is not known how this deficit relates to motor symptoms that are assessed routinely in the neurological clinic.